Optical probe would allow diagnosis without kidney biopsy, reducing complications
University of Houston researchers have identified a new, less-invasive method to provide diagnostic information on kidney disease and its severity.
In a paper published this month in the Journal of Biophotonics, Wei-Chuan Shih, assistant professor of electrical and computer engineering, and Chandra Mohan, Hugh Roy and Lillie Cranz Cullen, endowed professor of biomedical engineering, describe the use of an optical probe and Raman spectroscopy to differentiate between healthy and diseased kidneys.
Additional authors on the paper are Jingting Li, Yong Du, Ji Qi and Ravikumar Sneha, all of the University of Houston, and Anthony Chang of the University of Chicago.
Physicians traditionally use renal biopsy to directly observe kidney function. In addition to potential side effects, the number of renal biopsies a patient can undergo is limited because of damage to the kidney tissue.
For the study, Shih and Mohan did not look for a specific molecule or biomarker, such as creatinine, a molecular indicator of kidney function. Instead, the researchers relied upon the fact that a healthy kidney and a diseased kidney produce different Raman signals.
'There are some molecules that must be responsible for these different Raman signals, but we don't need to know what those molecules may be,' Mohan said. 'As long as there's a difference in the signal, that's good enough -- you can easily differentiate between a diseased kidney's Raman signal and a healthy kidney's Raman signal.'
Shih's expertise is in molecular sensing using light-based sensing technologies, such as optical probes. Mohan works on the genomics and proteomics of lupus and other autoimmune diseases, searching for new biomarkers and targets for treating autoimmune diseases.
Working together, the two realized that Shih's optical probes, which have been used for applications ranging from non-invasive glucose monitoring to sensing environmental hazards such as oil spills, could also be used to determine creatinine levels in patients with kidney disease.
'Raman spectroscopy provides molecular fingerprints that enable non-invasive or minimal invasive and label-free detection for the quantification of subtle molecular changes,' they wrote. 'It has the potential to largely reduce the complexity in diagnosing and monitoring anti-GBM (glomerular basement membrane) diseases. By adapting multivariate analysis to Raman spectroscopy, we have successfully differentiated between the diseased and the non-diseased with up to 100 percent accuracy, and among the severely diseased, the mildly diseased and the healthy with up to 98 percent accuracy.'
About 40 percent of lupus patients develop lupus nephritis, impairing their ability to effectively shed waste products and other toxins. Lupus nephritis is a leading cause of lupus-related deaths.
Earlier this year, Shih and Mohan collaborated on a paper published in Biomedical Optics Express to describe using the optical probes to provide a cheaper, faster and less invasive alternative to drawing blood to monitor a patient's creatinine levels.
Because creatinine has a unique Raman scattering signal, Shih said the optical probes can detect creatinine levels with far higher sensitivity than the chemical assay tests currently used. And the probe needs only a tiny sample of urine -- 5 microliters -- to provide an accurate reading.
For the work described in the Journal of Biophotonics, Shih and Mohan used mouse models with induced kidney disease to demonstrate the optical probe's ability to differentiate between a healthy and a diseased kidney without puncturing the organ. Shih's research team developed a metric to broadly quantify the level of disease using the Raman scattering signals.
'We are proposing the nephrologist will puncture the patient's skin, go to the surface of the kidney, and not puncture the kidney, but probe the surface of the tissue and acquire Raman signals,' Mohan said. 'The patient will feel a little pinch and poke through the skin, but the kidney is not hurt at all.'
The optical probe would be expected to result in far fewer complications, although Shih and Mohan caution that more research is needed before it can replace the kidney biopsy for patients with renal disease.
Jeannie Kever | EurekAlert!
Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences